488 related articles for article (PubMed ID: 11854157)
1. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
2. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2.
Ueng YF; Kuo YH; Peng HC; Chen TL; Jan WC; Peter Guengerich F; Lin YL
Xenobiotica; 2003 Jun; 33(6):603-13. PubMed ID: 12851037
[TBL] [Abstract][Full Text] [Related]
3. Modulation of drug-metabolizing enzymes by extracts of a herbal medicine Evodia rutaecarpa in C57BL/6J mice.
Ueng YF; Ko HC; Chen CF; Wang JJ; Chen KT
Life Sci; 2002 Aug; 71(11):1267-77. PubMed ID: 12106592
[TBL] [Abstract][Full Text] [Related]
4. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa.
Ueng YF; Wang JJ; Lin LC; Park SS; Chen CF
Life Sci; 2001 Nov; 70(2):207-17. PubMed ID: 11787945
[TBL] [Abstract][Full Text] [Related]
6. The presence of inducible cytochrome P450 types 1A1 and 1A2 in the BeWo cell line.
Avery ML; Meek CE; Audus KL
Placenta; 2003 Jan; 24(1):45-52. PubMed ID: 12495659
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
8. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract.
Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T
Drug Metab Pharmacokinet; 2005 Feb; 20(1):34-45. PubMed ID: 15770073
[TBL] [Abstract][Full Text] [Related]
13. Effects of Wu-chu-yu-tang and its component herbs on drug-metabolizing enzymes.
Ueng YF; Don MJ; Peng HC; Wang SY; Wang JJ; Chen CF
Jpn J Pharmacol; 2002 Jul; 89(3):267-73. PubMed ID: 12184732
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC
Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
Yao HT; Chang YW; Lan SJ; Yeh TK
Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
[TBL] [Abstract][Full Text] [Related]
16. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
Bourrié M; Meunier V; Berger Y; Fabre G
J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
[TBL] [Abstract][Full Text] [Related]
18. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.
Don MJ; Lewis DF; Wang SY; Tsai MW; Ueng YF
Bioorg Med Chem Lett; 2003 Aug; 13(15):2535-8. PubMed ID: 12852960
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes.
Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD
Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol.
De-Oliveira AC; Fidalgo-Neto AA; Paumgartten FJ
Toxicology; 1999 Jul; 135(1):33-41. PubMed ID: 10454222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
